• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Color Health Report Reveals Gaps in Employer Cancer Benefits

by Fred Pennic 02/05/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Color Health Report Reveals Gaps in Employer Cancer Benefits

What You Should Know: 

– Color Health, a provider of precision health solutions released its second annual Employer Insights Report, revealing a disconnect between employer priorities and the reality of cancer care benefits offered to employees. 

– The survey, conducted by The Harris Poll, explores how benefits leaders make decisions regarding cancer program benefits, including their current offerings, perceived effectiveness, and strategies for managing costs.

Disconnect Between Employer Priorities and Cancer Care Offerings

The survey revealed that employers’ cancer programs remain largely focused on treatment and management, despite benefits leaders recognizing the need for a more comprehensive approach to cancer care. Leaders emphasized the importance of resources beyond what is provided through their health plans, particularly for prevention, early detection, and post-treatment support.

Key findings of the report include: 

  • 88% of benefits leaders advocated for greater investment in prevention and early detection initiatives, a sentiment that persisted in 2024. In practice, though, 82% of benefits leaders reported spending significantly more on cancer treatment and management programs in 2023—a number that remained almost unchanged (81%) in 2024. 
  • 9 in 10 benefits leaders (91%) agreed that organizations should prioritize early detection and survivorship support alongside active cancer management, fewer than half (43%) have offered comprehensive cancer benefits as a strategy for reducing costs.
  • About three in four benefits leaders feel the need to expand their cancer offerings beyond what’s currently provided through their health plans (75%) or primary care providers (72%)—but only about 1 in 4 do, typically focusing on point solutions like survivorship support (27%) or genetic testing (24%) rather than comprehensive programs.
  • Benefits leaders identified the most critical cancer care benefits as: cancer screening and early detection (73%), treatment center networks and center of excellence (CoE) programs (67%), and cancer risk assessments (66%).
  • There has been no improvement in benefits leaders’ perception of cancer screening management by their health plan. In 2023 and 2024, nearly 3 in 4 (72%) agreed their health plan is not getting enough employees screened for cancer.
  • Most benefits leaders agree that the best ways to reduce cancer costs are through cancer prevention and screening (56%) and comprehensive benefits programs (52%) that span the full cancer journey.
  • Costs aside, benefits leaders cited support for employees’ mental and emotional health as their top concern – but only half (54%) offer enhanced mental health and emotional support services for cancer patients and survivors.
  • 93% of benefits leaders agree that their organization should invest more in supporting cancer survivors as they transition from treatment back to health – but only 1 in 3 (33%) offered dedicated cancer survivorship programs in 2024.

“As cancer rates climb among working-age individuals, employers are recognizing cancer as an increasingly common concern in their employees’ lives, not to mention for their business,” said Josh Sturm, Chief Revenue Officer at Color Health. “Benefits leaders need help bridging the gap between awareness and implementation of comprehensive cancer programs. At Color, we are 100% focused on cancer and have built the only Virtual Cancer Clinic, which goes well beyond care navigation with an in-house medical group that cares for everyone on your team – in every state of the country.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Cancer Diagnostics, Oncology

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |